Skip to content
healthcare.dev

Buprenorphine and Naloxone

NDC 67296-2164, Buprenorphine and Naloxone, tablet, from Redpharm Drug.

Product NDC
67296-2164
Status
Listed
Labeler
Redpharm Drug
Dosage form
TABLET
Route
SUBLINGUAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA205601
DEA schedule
CIII
Request
curl https://api.healthcare.dev/v1/drugs/ndc/67296-2164 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BUPRENORPHINE HYDROCHLORIDE8 mg/1
  • NALOXONE HYDROCHLORIDE DIHYDRATE2 mg/1

Pharmacologic classes

Opioid Antagonist [EPC]; Opioid Antagonists [MoA]; Partial Opioid Agonist [EPC]; Partial Opioid Agonists [MoA]

Package NDCNDC-11Package
67296-2164-16729621640112 TABLET in 1 BOTTLE, PLASTIC (67296-2164-1)
67296-2164-6672962164066 TABLET in 1 BOTTLE, PLASTIC (67296-2164-6)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/374530e2-3b2e-77d7-e063-6394a90a37c9

Use it

Look up 67296-2164 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/67296-2164 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 67296-2164. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.